The Advisory Board Company (NASDAQ:ABCO) Yearly Sales Target At $226.39


The EPS projection of The Advisory Board Company (NASDAQ:ABCO) for quarter ended 2016-09-30 is $0.33. A week before, the EPS forecast was $0.33 against target of $0.33, a month earlier. This estimate stood at $0.33 60 days earlier versus forecast of $0.33 90 days earlier, confirming a deviation of 0%.

The Advisory Board Company (NASDAQ:ABCO) reported that 18 days ago, the positive EPS revisions were 1 and negative revisions at 1.

In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 1, 2, 0 and 2, respectively.

The downgrade of EPS estimates for The Advisory Board Company (NASDAQ:ABCO) in the preceding 120, 60, 30 and 90 days were 1, 1, 0 and 1, in that order.

Earnings Surprises

As per the latest update, for the quarter closed 1, the EPS estimate of The Advisory Board Company (NASDAQ:ABCO) was $0.33. This projection was computed after accounting 5 calls. As reported on 2016-05-05 the EPS was $0.35. The change was $0.05, demonstrating a percentage deviation of 16.67%. The projections confirmed a standard deviation of 0.02.

Quarterly Sales Estimates

For the fiscal 2017, the yearly sales target for The Advisory Board Company (NASDAQ:ABCO) stands at $226.39 and the median estimate at $226.5. Almost 4 analysts announced their estimates.

The highest estimate is $226.6 while the lowest target is $225.96 showing standard deviation of 0.29%.

As many as 4 analysts released sales estimates reised in upside while 4 reduced sales estimates, demonstrating a deviation of 0%.

In last month, 4 revised sales number projection on upside while 4 lowered the sales target, demonstrating a deviation of -0.557%.

A quarter ago, 4 hiked sales estimations and 4 reduced sales forecast. The Advisory Board Company (NASDAQ:ABCO) stated that the change in forecast was -0.536%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 4 times, 1 visits today)